InvesT1D: Promoting Adolescent Investment in Diabetes Care
This study, called InvesT1D, is looking at whether giving financial incentives (money) can help teenagers with type 1 diabetes better manage their condition. Participants will be between 12 and 18 years old and have had type 1 diabetes for at least a year. They also need to use a continuous glucose monitor (CGM) and either use it less than 70% of the time or give themselves insulin shots (boluses) less than 3 times a day on average. Some teens will receive financial rewards for reaching diabetes goals, while others will continue their usual care. The main goal is to see if these incentives improve their "Time In Range" (how long their blood sugar stays in a healthy range) over 12 to 18 months. Researchers will also look at how teens and their caregivers feel about their diabetes management.
- Study design
- This is an interventional study with 96 participants. Participants will be assigned to one of six groups, some receiving financial incentives and others continuing usual care.
- What's involved
- Participants will choose diabetes self-management goals, such as increasing daily insulin shots or CGM wear time. Researchers will collect data from participants and their caregivers.
- Compensation
- Participants in some groups will receive financial incentives (money) when they meet their selected goals.
- Follow-up
- Changes in glucose levels will be measured over 12 to 18 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
InvesT1D: Promoting Adolescent Investment in Diabetes Care
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Time In RangeChange over 12-18 months
Continuous glucose monitor sensor glucose measurements collected during the intervention that are in range (70-180 mg/dL)